TBBA (TBBA) Stock Price & Analysis
TBBA (TBBA) fell 0.31% to USD 6.5 as of June 10, 2026 at 02:16 UTC, according to Nexqual real-time market data.
TBBA last closed at USD 6.52; the session ranged USD 6.5–6.5 on volume of 2,407 shares. Market capitalization is $17.06M, with a 52-week range of USD 5.45–8.26 (OID). Source: Nexqual, June 10, 2026 at 02:16 UTC.
Key Statistics (as of June 10, 2026 at 02:16 UTC)
| Price | USD 6.5 |
|---|---|
| Change | ▼ 0.31% (down) |
| Previous Close | USD 6.52 |
| Open | USD 6.5 |
| Day Range | USD 6.5 – 6.5 |
| 52-Week Range | USD 5.45 – 8.26 |
| Volume | 2,407 shares |
| Market Cap | $17.06M |
| Exchange | OID |
Technical Analysis (TBBA)
Nexqual's technical model rates TBBA "NEUTRAL" based on 3 bullish and 2 bearish signals across 123 daily candles, as of June 10, 2026 at 02:16 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.44 (neutral) |
| vs SMA50 | Below (USD 6.53) |
| MACD | -0.03 (negative) |
Analyst Ratings (TBBA)
Wall Street analysts rate TBBA "None", per Nexqual as of June 10, 2026 at 02:16 UTC.
| Consensus Rating | None |
|---|
Earnings (TBBA)
Source: Nexqual, June 10, 2026 at 02:16 UTC.
Financials & Fundamentals (TBBA)
| Total Revenue | $10.45M |
|---|---|
| Revenue Growth (YoY) | -38.80% |
| Gross Margin | +0.00% |
| Operating Margin | +14.67% |
| Profit Margin | -12.56% |
| ROE | -4.62% |
| Total Cash | $26.04M |
| Total Debt | $5.00M |
Source: Nexqual, June 10, 2026 at 02:16 UTC.
Financial Health Score (TBBA)
Nexqual rates TBBA's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:16 UTC.
| Growth | Critical — Revenue -39% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — $26M cash vs $5M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$4M |
| Efficiency | Critical — ROE -5%, ROA -0.4% |
Ownership (TBBA)
| Insider Ownership | +52.51% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.62M |
Source: Nexqual, June 10, 2026 at 02:16 UTC.
Leadership (TBBA)
TBBA is led by Thomas Sattler (age 60), President, CEO & Director, per Nexqual as of June 10, 2026 at 02:16 UTC.
| President, CEO & Director | Thomas Sattler (age 60) |
|---|---|
| Chief Financial Officer | John P. Udvare (age 60) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma, Inc. | USD 0 | ▲ 0% |
| BRSF | BRAIN SCIENTIFIC INC | USD 0 | ▲ 0% |
| QNTO | Quaint Oak Bancorp, Inc. | USD 16.85 | ▲ 0% |
| FRSB | FIRST RESOURCE BANCORP INC. | USD 22.39 | ▼ 0.49% |
| TYCB | Calvin B. Taylor Bankshares, In | USD 52.56 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:16 UTC. This page is informational and not investment advice.